westlake kechemical. they should move up. >> don't go anywhere. "mad money" with go anywhere. "mad money" with jim cramer starts right now. my mission is simple, to make you money. i'm here to level the playing field for all investors. there's always a bull market somewhere, and i promise to help you find it. "mad money" starts now. hey, i'm cramer. welcome to "mad money." welcome to cramerica. other people want to make friends. i'm just trying to make you some money. my job is not just to entertain but jatd. to so call me at 1-800-743-cnbc or tweet me @jimcramer. sell the news. the trump rally is tired. the guy's to divisive. he'll never get anything done. time to take profits.

ring the register! 24 hours ago, all i kept hearing was sell the news. the trump rally is tired. the guy's too divisive. he'll never get anything done. time to take profits. oh, you heard it too. the bulls long in the tooth. the rotations are over. a lot of really smart guys said it's time to get out. buy the puts. put on the shorts. >> sell, sell, sell. >> well, they shouldn't look all that smart today. dow surging 303 points. s&p pole vaulting 1.37%. nasdaq soaring 1.35%. >> hallelujah! >> this is why i always say that group think is so dangerous. many revered money managers came out in the last two months and said we're doomed in part because they disdain trump's bust the budget ill informed analysis of what happens next. that's how they put it. in fact, it got so bad that even the great warren buffett was taken to task for saying this market's not in a bubble. if you think it's over, you're simply on the wrong side of

history. someone actually told me that buffett has become that old gas bag polyanna from omaha, something that seemed to have a lot more gravitas 24 hours ago than it does now. look, i hate to get roped back into anything even touching politics. you know i've been of the opinion that we need to stop empathizing stock as a reason to buy stocks. the presidency is important, but not that important. sure, we want to believe in the economic plans, but there's been so much of other good stuff happening, including worldwide, growth that has nothing do with the occupant of the oval office. in the last few weeks we've seen strong numbers develop. japan, germany, britain. meanwhile, brazil, russia, indiana and china are producing some very positive economic data that shows the world's finally being restored maybe back perhaps to the pre-crash growth levels. i made this argument over and over because i didn't want anyone to sell stocks betting

that washington had gotten too rancorous for the president to get anything done or that we were developing some new form of gridlock. call it trump versus everybody. i told you that even if it seems like nothing's going to get done, ultimately congress will likely pass the most effective parts of trump's economic agenda if only because there's an election every two years. these lawmakers want to keep their jobs. i pointed out last night that maybe it would actually be better if the tax courts and repatriations were pushed out if only so there would be something positive in the future to keep this market going. but what i didn't count on, i think what hardly anyone counted on, was the president who showed up in front of the joint houses of congress last night and spoke in measured, hopeful tones. a president who was, well, presidential. now, i want to be really clear. i'm not making any kind of political argument here or judgment. i'm just saying that style matters in politics, and the

style we saw last night makes it a lot harder for trump's opponents to fight his economic agenda. you may love the firebrand, media trash talking trump, the one that throws the bombs on twitter. but the simple fact of the matter is that before last night, we had been hearing that some republicans would break ranks with the president, making it almost impossible to get anything done. after the more conciliatory trump we saw last night, whether you consider him an actor, a showman, a truth teller, the shoe is now on the other foot. meaning people are wondering which democrats might break ranks. come around to the idea of a tax holiday or the repatriation of foreign money which can then be spent here or lowering the corporate tax rate which might spur companies to hire more people. heck, he might even get republican support for his trillion dollar infrastructure plan. look, the gop hate any spending, right? that's been their rap for years. the impossible 24-hours ago now

seems down right likely today, which is why we put on such a mag mag nif centrsent rally. the secret behind this one? the sell the news notion that it had become the mant ra of all the smart guys. they're always so smart. smug smart. i love to listen. they're like geniuses. you know, geniuses. anyway, they all believe that we've gone as far as we can with trump. we've had the 13-day record-breaking winning streak. that's in the past. we had that bank stock run, ended long ago. we saw the industrials peak out. material stocks have begun to roll over. what's often the final rotation for a bell selloff, the more pouring into defensive stocks and we already had that. the market had been millenniallesmillennialifeless. it had become dull. we even some major blowups for the first time.

the collapse of target stock. that was like a fire alarm warning us that we were overstaying our welcome. claxen. in short she thought it was time to sell stocks or even short them. of course that's all turned out to be wrong. first, you never short a dull market, ever. second, in a classic bull market full of rotations, the groups that rallied first tend to consolidate and go higher just as they're doing today. third, i see your target, and i raise you lowe's, the gigantic do it yourself big boxer. they reported a monster good number. and finally maybe imprinting what i've been saying forever, which is the consumer is spending on her home, staying at home, playing and feasting at home just so that mcdonald's getting on the delivery bandwagon, the one that's taken domino's from 10 to nearly 190. i remember steve easterbrook rur urging everyone not to sell stock because of annualizing all day breakfast.

but there's one more thing at work here that we don't spend a enough time talking about. i'm going to take it slowly because i know it's going to cause some derision, but that's okay. no stranger to being derided. this is a bull market. when i got into the stock market in 1979, you know what we used to have? we had bear markets, and we had bull markets. you could freely admit thaw were -- that you were in one or the other. there was never any harm in recognizing the bull. maybe some people even cheered. that all changed with first crossing of dow 10,000, which clearly led to too much optimism. these proved to be disastrous milestones for investors, and it wasn't much better to see that run-up to the great recession in 2009. so what happened? for years and years now, anyone

who is boisterous about the stock market, anyone who said this bull is hard to bet against instantly makes themselves a target because it's so easy to call up the tape and see how wrong the prognosticator was if things go bad. it can be career suicide via social media. we never castigate all those money managers who told you to get out. remember all those ones who told you to sell, sell, sell? they're never confronted for scaring you out of tremendous profits. that's because the bears always get a pass, always. i mean always. they get the free lunch. as much as i wish these guys would be held to account, the fact is that they took the percentage play. a few weeks ago i came out here and said the bull is hard to bet against. i then followed the comments on social media where i have more than a million followers, and i can't tell you how many tweeted something like, when cramer says buy, that's the top. i'm selling everything. or get out now.

you have to bet against this clown. i've learned to take the haters in stride, and i am grateful to my eldest daughter, who taught me to hit these people were smiley faces and then block them. you know? like the ones with the sunglasses. those are the best, aren't they? by the way, the people who said that i was wrong, ill advised. so here's the bottom line. if everyone's cowed and so few have the courage to say this is a bull market and it's hard to bet against, then you're going to get have moments like today where the whole thing just explodes higher, levitates, and that coupled with a kinder gentler trump explains the snort and the roar of a very live bull trampling over the bears in one amazingly positive session. why don't we go to will in

california, will. >> caller: hey, jim. a great big booyah from southern california. >> i'm liking that. what's up? >> caller: with the recent step down of ralph lauren's ceo is right now the right time to buy ralph lauren corporation? >> you know, here's the problem. look, i no offense to ralph. it could be any apparel company. apparel is a tough, tough business. my dad sold gabber deens and my mom sold women's launch ray so i know where of i speak. it's too tough. we got so many other areas that are going great. why do we have to go into ladies lingerie and men's apparel? my father sold gabber deens by the way. do they make gapper deens? no. quinton in my old home state of pennsylvania, quinton. >> caller: how are you doing, jim? >> i'm doing great. how about you? >> caller: i'm doing great. thank you. >> there are a couple guys sitting around being great. >> caller: my question is dell

taco's quarterly reports are coming up and the stock's been dropping. is this a good time to buy? >> no, man. that taco game is a tough game. geez, i mean even my buddies over there at the chipotle, they're making a comeback. they've got another four months. but taco and the fiesta restaurant group, no. look, if i have to do food, i'll order in. okay. this is a bull market and it's hard to bet against. i said it again. cramer he a clown. where's the bozo? can we get like a snap that has bozo or make me into a squirrel or something? if only more investors could just accept that it is a bull. on "mad money" tonight, what lies ahead for the drug stocks in a trump era? i'm taking the temperature of the sector when i tackle the technicals in tonight's off the chart. then speaking of trump, last night the president called on congress to pave the way for a trillion dollar infrastructure package. i'm eyeing two plays in the space that nobody's talking about. and viva systems is up over 90% in the past year.

a lot of shorts really got crushed by it, but it's had a roller coaster ride in the last 24 hours. the facts behind the fireworks just ahead. stay with cramer. >> announcer: don't miss a second of "mad money." follow @jimcramer on twitter. have a question? tweet cramer, #madtweets. send jim an e-mail to madmoney@cnbc.com or give us a call at 1-800-743-cnbc. miss something? head to madmoney.cnbc.com.

what's critical thinng like?? a basketball costs $14. what's team spirit worth? (cheers) what's it worth to ta to your mom? what's t vue of a walk ithe woods? the value of capital , whnot just wealth, but things that matter. morgan stanley

lately the big pharma stocks have been totally on fire. the popular theory especially on a day like today where the market roared in response to president trump's non-statement of the union arrest is that the bottom was put in on a group of executives that met with trump and convinced him not to crack down on the industry. that's definitely part of it, but i think this move has more to do with the fact these stocks are high-yielding bond market equivalent names and until the past few days, buying yields were going lower, which makes

any kind of dividend stock more attractive. but the earnings are looking better than we might have expected. now the more important question is can the pharma rally continue? and that's why tonight we're going off the charts with the help of bob language, the brilliant technician in the three-man all-star time behind the tree.com's trifecta stocks newsletter, it's been hot as a pistol, to get a better sense of where this group might be headed. >> in lang's view, pfizer, merck, eli lilly, allergan have been displaying good relative strength and could have a lot more room to return. this is important, people because you're wondering is there anything left to buy after this rally. the whole cohort was pounded last summer as everyone, especially hillary clinton, got up in arms about overly aggressive drug pricing. then when hillary lost the election and the stock started to rebound, trump came out and said he wanted to krablg down on these same practices, swiftly

sending the cohort lower again. for five months, pharma was a toxic sector. but as i mentioned earlier, the group has made a big turnaround in 2017, and this is what's important. lang thinks it can continue. so let's go through these names one by one, starting with pfizer's weekly chart. i haven't looked at this one in ages. if you look at the last six months, lang points out pfizer has been making a bullish w pattern. this is the kind of bottom formation that suggests the rally in this stock is just getting started. when i did get rich carefully, i found the w pattern to be the strongest pattern in terms of what a stock was about to do. yeah, that's right. this is sleepily old pfizer and bob langthys it's got the best chart of the bunch. it's made a series of higher highs. that's an oscillator which measures the level of buying and selling pressure in a stock, giving ah sense of what the big institutional investors are dog. it's just about to turn positive. you can see that, right? lang says the last time that happened, well, guess what?

pfizer rallied 20%. at the same time, the option flow here has been very bullish of late. heavy buying interest in call options which really does matter, all right? the moving average convergence, divergence, an important momentum gauge that helps technicians spot change before it happens. you can see this breakout right here. i think that matters. that's a bullish crossover. that's the black line crossing over the red line, all right? that's another signal that pretty reliably predicts higher stock spices. and rsi, another momentum indicator, it's been rising nicely. pfizer rallied 10% last month alone. put it all together, and lang thinks this is a very, very pretty picture. it really is standard. it's got the w. it's got the bullish cross. strong rsi. i see why he says this is the best chart. next up, take a gander at merck's chart. a lot of people own merck.

unlike the rest of the pharmaceutical space, merck had a great year in 2016. nice, huh? that rally has only continued in 2017. from fraser, good job. stock up 50% since the beginning of last year. lang know it's been rep lentless wrong on very strong buying. for charters, volume is like a lie detector. any move on strong volume is a move that's telling the truth. even better, the mac d indicator, it just made -- there we go again. the bullish crossover that was a few weeks ago. just this week, merck broke out above the long term ceiling that really kept it lower. it kept the lid on 64 bucks, making new all-time high lang likes this chart and thinks merck isn't finished going up, which to me makes a lot of sense because it's got that newfound anti-cancer prowess.

this is when their drug beat bristol-myers's drug, and that was very important. it's called keytruda. how about eli lilly? let's take a look at that one. after spending more than a year stuck under 82 bucks, there was your ceiling. look at that. it kept trying, kept trying, kept trying. lilly just broke out above that ceiling on very strong turnover. there you go. got that right there. that's important. ever since december, this stock has been taking off like a rocket, up nearly $20 in three months time. the mac d line made a bullish crossover at the beginning of the year. mile we may be late in the party with the rally in eli lilly, it's good evidence that the recent bullish crossovers in merck and pfizer could be foreshadowing similar moves. lang also notes the relative strength indicator has been climbing with a pretty steep slope, which is what you'd expect to see with such strong actio action. ic lilly's recent breakout takes

the stock above the double top levels. i feel like you might be chasing with this one but i got to tell you lang says it's got more room to move. i've been kicking myself about it as i wanted to go out and tell action action club members to buy little by because of it's burgeoning dienz franchise. no bull back in this. look at this thing. no pullback. one more, all right? take a look at the chart of allergan. this is one i like but i got to tell you this is probably the worst -- probably the worst of the group. let's take a look at it. those of you who watch the show regularly, you know i own it for my charitable trust. last year, this stock, okay, got taken to the wood shed. this is what you're seeing. this was just the vast breakdown. that was because pfizer tried to acquire them and the government blocked the deal. also because of the drug pricing issue, even though allergan was one of the few pharma companies that took concrete steps early and often to avoid gouging its

customers. just watch our interviews with brend saunders. allergan is a good corporate citizen with a truly amazing pipeline. in the last few months, the stock has finally started getting credit for that pipeline. lang points out this chart shows -- you might not agree with it, but it says a bullish w, okay? to me it looks more like a w scrawled by a kindergartner who is just learning the alphabet, like my executive producer's kids were to do it, it would be like that, okay? >> very nice w. >> yeah, yeah, sure, sure. >> bring in an example of their work tomorrow. >> all right. on top of that -- keep talk, all right. it's my show, not your show. when you get your own show, you can get all the ws you want with your kids. >> this is my show. >> w. w. could you cut the string so i could finish this segment? on top of that, allergan -- cable access -- broke its down

trend line. you know, like channel 38. making both higher highs and lower lows as it rallied. the that's the action charters like to see. sure enough, the mac d did a bullish crossover in late december and since then it's been climbing along with the stock. lang says the relative strength index looks solid. the shake and money flow oscillator, not that good, but he thinks it would turn positive if the stock caught a little bit more of a rally. even though allergan had a pretty epic move in the last few months, lang believes it's just getting started and i have to agree with him although i think that w is -- well, we've covered that. here's the bottom line. whatever the cause of the recent rally in big far marx the industry reaching an accommodation with the president or the decline and fall of the bond market, the charts as interpreted by bob lang suggest that pfizer, merck, eli little by, and allergan could have a lot more room to run. possibly a huge amount. now, remember, lang says

pfizer's chart is his favorite. but on the fundamentals, i got to tell you, i got to stick with allergan as it's rolling out six potential blockbuster drugs this year. this is great news for everyone who feels like they've missed the move as none of these stocks are historically expensive. and almost every one of them can be bought right here. but please leave some room for a pullback if we ever get one in this remarkable rally. we got tons ahead here. one of the few things both democrats and republicans seemed to agree on last night was trump's focus on infrastructure. so we're focusing on infrastructure. which companies could be long term winners under the president's plan? i'm eyeing two that could pay regardless of policy. probably want to write them down. then the biggest names in health care are calling on the cloud to treat their data needs. and viva systems is on the front lines. can the company continue to support the surge in patients? plus should this market take a lesson from the hit tv show "law

and order"? yes. i'll explain how it relates to salesforce's move yesterday. i say stick with cramer.

i will be asking congress to approve legislation that produces thproduc produces a $1 trillion investment in infrastructure for the united states, creating millions of new jobs. >> last night the president talked about his $1 trillion infrastructure plan, which as we predicted with our table pounding on the stock of martin marietta, sent all the infrastructure plays soaring today. i've talked about many of these and tonight i want to highlight two more because i really think they fit the program here. one is called m core group, eme shs the other mtz. i haven't talked about that either because we got a real dilemma in this business.

it's simple. are these trump stocks? >> trump stock, trump stock, trump stock. >> meaning do they need this infrastructure bill to pass in order to keep on climbing, or do they have the potential to be -- >> frutrump free zone. maybe they can rally without the help of legislation. first let me introduce you to these companies. mcor and mastec. emcor is a construction contractor for infrastructure. they also offer care and maintenance services for buildings as well as performing ultra-specialized maintenance projects for the refining and petrochemical industries, meaning this baby has got oil exposure. mastec is another smaller infrastructure construction company that operates across a range of industries including renewable energy, communications, electric power, water treatment technology deployment, and all sorts of government work. although the vast majority of the business comes from communications and energy. now, these stocks have had some

epic runs since the election as trump's pro-infrastructure program gave the whole sector a boost from his come from behind victory. mastec is up an astounding 40% since the election, emcor ran up 12% but then the company reported a less than stellar quarter last week and the stock gave up most of its gains, which intrigues me. question number one, are these trump stocks? on the campaign trail our new president was always talking about building new roads, bridges, airports, school, hospitals. in last night's speech, he used the trillion dollar number although it's a little misleading because he doesn't want to actually spend that much money. he just wants to issue tax credits so that companies will invest in $1 trillion worth of projects. since trump was sworn in, this whole endeavor has gotten a lot more questionable. regardless of the excommitment, we've got a republican

controlled congress that hates spending money. plus some critics say using tax credits just amounts to a giveaway to companies that would have built these projects anyway. whether or not you think that criticism is valid for our purposes, it really doesn't matter. we love corporate welfare here on "mad money" because we're all about finding companies that will make lots of money. like it or nod, government giveaways still count. for mastec, and emcor what matters is getting congress to pass any infrastructure bill. last night's speech notwithstanding, it seems like this won't be happening anytime soon. before the gop does anything else, their number one priority is figuring out health care and it could take a very long time for them to come up with a replacement for obamacare that can pass both houses of congress without causing too much fallout. even if we get to the point where there's a real bill on the table here actually being discussed and debated, the president is almost certainly going to need some democratic cooperation. while this is the kind of thing that dems would usually go for, the truth is that our system really doesn't reward bipartisan cooperation anymore. so i've become a lot more

skeptical that this can happen. if we do get a big package, though, that would be extremely positive for both emcor and mass tech, even without an sfrurk bill, these two companies stand to benefit from the trump administration because they both do work in the oil and gas space where you know our new president has a very accommodating attitude toward's pipeline construction, and that's right in mastec's wheel house. regardless of what goes on in washington, i think both companies are poised to do well in an expanding economy. emcor gets a little complicated here. while the stock exploded higher right after the election, it got pummeled last week after it reported a subpar quarter. it posted an 11 cent earnings miss, a big miss, off an 83 cent basis, slightly higher than expected revenue, weaker than anticipated full-year guidance. so the stock got clubbed, went down 10%. however, i think you could be getting an excellent buying opportunity right here in this stock with a potential trump kicker if congress can figure out how to pass an

infrastructure bill. why am i so sanguine after the stock got crushed air week ago? first of all, a customer refusing to pay for cost overruns, that's not going to happen again. while guidance didn't give you much to get excite the about, the truth is it's very conservative. it excludes any kind of sales and earnings games from big new projects even though there could be a number of them waiting in the wings. some of emcor's largest end markets, they're looking pretty good here. in short, i think it settles s p for a classic u-pod situation. underprovis and overdeliver, and i love upod. how about this red hot mastec. it's ramped since the election and it reported an excellent quarter last week. sent the stock up 8% in response. it was one of the biggest gainers that day. this was a huge 16 cent earnings beat off a 54 cent basis with higher than expected revenue and robust guidance for both the next quarter and the full year.

in fact, it's forecasting a record year in 2017 for both revenues and earnings. the reason? part of it has to do with communications. you see, a huge part of the business where m parks stec is expecting a major uptick is build of the build out of 5 g wireless infrastructure that so many of us have been waiting for. management also gave a nod to the trump administration's position on easing regulations, something that could have a positive impact on the number of pipeline projects that they're building and projects in general. while mastec didn't mention anything about corporate tax reform, if congress can stop dragging its feet and pass the president's plan, this would add 78 cents to the company's earnings per share. it is really a trump stock. in both, both stand to benefit from trump's initiatives. both are likely to succeed, and the long shots that might have a harder time getting through the legislative process. even without help from washington, i think these could end up very well. emcor because of growth in

non-residential construction, mass tek because it's communication business will blast off. both companies benefit from the turnaround in the oil and gas business and made easier by the most pro-fossil fuels president in history and the need for billions of dollars in pipelines to get the natural gas from the north to the south and export it overseas. here's the bottom line. emcor and mastec are quintessential trump stocks, the kind that have a right to roar. the new, kinder, gentler trump comes to the hill more often these are going to higher. they could benefit enormously if the president gets his way on a host of issues, but they're also trump stocks that may not even need trump. >> trump stock. not a trump stock. >> ween without an infrastructure bill, these companies still should do very well. i like emcor as a value play, and mastec is on fire although i hate to chase. so let me suggest for that one you wait for a pullback and then you do more buying. but if you can't resist, and i understand if you can't because it is such a good stock, buy

some now and wait for the rest to come in. mary in new york, mary. >> caller: hey, jim. thanks for taking my call. my question is on smith and weszen, now american outdoor brands. >> yes. >> caller: i'm long around 29. would you buy, sell, or hold before earnings report? >> i just think this -- i don't think the earnings report is going to be that bad. even if it isn't that good, i think it reflects down 7% if things aren't so good, so i'm okay with buying it. it's interesting they changed their name because i actually think that smith & wesson was fine. but it's kind of gotten lost in the shuffle. i think people don't recognize that. that's also hurt the stock. nick in texas, nick. >> caller: hi, jim. first of all, i'd like to say happy dow 21k booyah. >> yeah, why not? i think that's fine. what's going on? >> caller: the company is sha near energy. so january proved u.s. shell gas imports to be costly compared to other nations. we got growing competition from future players such as tillier,

shell. >> absolutely. >> caller: however, chenneer is already operating so they have a head start on the competition, and the current administration seems to bode well regarding energy and deregulation. how do you play it from here? >> i think you play it with the chenneer energy partners lp, the one that's going to give you a 5% yield because i don't think rates are going 0 to soar. remember, i'm not as big as a fan of l and g as i was because sharif suki was fired and i think ef was the genius behind the company. i'm just saying. got us in at 8 bucks. trump stocks that may need or may not need trump. i don't know. if they don't need trump, it doesn't get any better. emcor and both msatec on pullbacks. much more "mad money" ahead. last night trump took a swing at the fda's approval process. what could deregulation mean for viva systems? i'm going to sit down with the ceo to find oud. then are stocks guilty envelope prov -- until proven innocent in this market?

and all your calls rapid fire in tonight's edition of the lightning round. so stick with cramer.

bp gives its offshore teams 24/7 support from onshore experts, so we have extra sets of eyes on our wells every day. because safety is never being satisfied. and always working to be better. because safety is never being satisfied. but they didn't know they were all tobacco products.e... ooh, this is cool. it smells like gum. yummy! this smells like strawberry. are these mints?

given that 80% of kids who ever used tobacco started with a flavored product, who do you think tobacco companies are targeting? do we get to keep any? now that the drug and the biotech stocks have come back

into favor in the wall street fashion show, what do we do with the arms dealers of the pharmaceutical industry? take veeva systems, a cloud-based software company that gets its start by helping to make pharmaceutical sales reps more efficient. but now has a platform that makes the whole life science industry more efficient while also ensuring that its clients com comply with regular lagsz. it's been red hot. the stock is up more than 90% in the past year including nearly 10% gains since the beginning of to 17. it could have more room to run. last night the company reported a strong quarter, posting a 5 cent earnings, higher than expected revenue, up 31% year-over-year. guidance came in a little light. i think management was being conservative with its fork. don't take it from me. let's check in with peter gassner. he's the founder and ceo of veeva systems. mr. gassner, welcome back to

"mad money." >> thanks, jim. glad to be here. >> reporter: peter, last time i saw you we were talking about vault, and you had a nice suite of products. but now i think you've made the suite gigantically. so why don't you tell our viewers what sets vault apart from other cloud-based content management systems and while it's unique also for the life science sector? >> vault really is going well for us, jim. as you remember, we went public about three years ago and vault was a $15 million business. now it's at a $220 million run rate. actually last quarter we announced we signed our two biggest vault deals ever. so it's really taken off. but if you want to unpack that, why is it taking off? it's a unique platform that we need for our life sciences customers. it handles content like documents, videos, et cetera, but also data. data points about attributes of documents. it handles that all together, and it's actually the only kind of platform that does that. so we use that to build these robust applications for life sciences. >> i think it's important to

tell people because i'm a big believer in revenue growth, where your company stacks up against salesforce particularly because at one time you worked for salesforce. >> yes, i did work for salesforce and ibm before that. so we've done well since our ipo, we've actually doubled -- more than doubled our revenue and tripled our profit. that's one of the hallmarks of veeva. we have this high-growth and strong profit. that's something you don't often seen in cloud companies and that has to do with the way we are and the way we approach things. but more to the point, where we're going, going forward, we're building this multi-billion dollar company and this year we actually crossed the half billion dollar revenue mark for the first time. smaller than salesforce.com, but they're our partner in this. we work together with salesforce.com. we serve joint customers. we've got a really great ten-year partner with them. >> on the conference call, you said we are at the start of a major transformation cycle in regulatory technology. talk to me about that cycle and

where vault fits in. >> yeah. vault -- the regulatory cycle, that's where our customers have to register these products for sales, medicines for sales all around the globe. it's a complex process and we're at the start of these companies refitting their technology. we closed two of the top 20 companies in the first quarter. we're looking for success with those companies. you know, over time, selling more to those large companies and small companies. it's something we set out to do two years ago, jim. we really started building this application, and now we're glad to see the customers adopting it. couldn't be more thrilled with that. >> like another one of our favorites, workday where aneel bhusri developed one line and then expanded. you're doing deals outside which i think could carry the company further. could you give us some details?

>> absolutely. this is based on our vault platform. we have a couple of our vault applications that we're going to bring outside of life sciences. this has to do with quality software, quality management. you know, managing work processes and procedures and who changes those procedures so we can bring these to industries outside of life sciences like chemical manufacturers, consumer packaged goods and other highly regulated industries. we just started to do that last year with an application suite we call vault quality one. we already signed two initial projects with a couple fortune 500 companies that have to be top 30 chemical manufacturers and we're really excited about that because we can bring the benefits of the vault platform to all different kinds of industries. >> just in terms of current events, the president has been saying he's going to streamline the fda. that's a tough thing to do because the fda wants to protect us. what's the scuttlebutt in the industry about whether there could be deregulation in the

fda. >> i think they're streamlining going on all the time in the fda. they're continuing to improve, and the life science industry is improving because we're starting to really meet some of these unmet needs in life sciences, you know, cure some illnesses that haven't been cured before, going after some orphan diseases. so i think the streamlining is always going on, and i'm really happy to see the dialogue about that. the government and the industry working together to serve the patients better. >> all right. that's peter gassner. he's the founder and ceo of veeva systems off a record quarter. thank you for coming on "mad money." >> thanks, jim. glad to be here. >> all right. this is another software service stock that has a great market and it's getting bigger. "mad money" is back after the break. this car is traveling over 200 miles per hour. to win, every millisecond matters.

both on the track and thousands of miles away. with the help of at&t, red bull racing can share critical information about every inch of the car from virtually anywhere. brakes are getting warm. confirmed, daniel you need to cool your brakes. understood, brake bias back 2 icks. giving them the agility to have speed & precision. because no one knows & like at&t.

>> announcer: lightning round is sponsored by td ameritrade. it is time! it is time for the lightning round on cramer's "mad money." that's where i take your calls rapid fire. you tell me the name of the stock. i tell you to buy, buy, buy or sell, sell, sell. we'll play this sound -- [ buzzer ] -- and then the lightning round is over. are you ready, skee-daddy? it's time for the lightning round on cramer's "mad money." let's start with jim in north carolina, jim. >> caller: jim, opko health and

can you invite dr. frost back to your show? >> phil frost has a standing invitation. in the meantime, that stock has no longer got the -- let's just say he needs to come on because i'm starting to think that last acquisition was a real buzz kill. let's go to bob in new jersey, bob. >> caller: booyah, jim. >> booyah. >> caller: my stock is fireeye. >> no, we're not going fireeye. we're not going palo alto. remember when we had chuck robbins from cisco on, made it very clear the one we're going to like in that area is cisco and not any others. cisco is kicking butt. let's go to alex in florida, alex. >> caller: how you doing, jim? booyah. >> i'm doing well. how about you? >> caller: good. the only stock down in my portfolio, kbr. i want to know what to do. >> yeah, you know, i like the infrastructure stocks. it wasn't that good a quarter. i'm going to say it's okay. i'm going to say it's okay. it's not a bad company. it's got a lot of cash. how about hillary in louisiana,

hillary. >> caller: hey, booyah, jimbo. ex-jersey boy from the jersey shore. survived mardi gras yesterday. >> good for you. >> caller: i bought a lawn mower 23 years ago and it's still going, and it will not quit. not sure if you ever mentioned this one. toro. >> no, i haven't and it's a very reliable 3wr57bd. sometimes that's enough, but we're going to do a number on that one. we have to do more work. i can't just tell you it's a reliable brand. let me come back. and that, ladies and gentlemen, is the conclusion of the lightning! [ buzzer ] >> announcer: the lightning round is sponsored by td ameritrade. figure outhis compld so i brought in my comfort pony, rren, to help me dl. isn't that rightarren? well, you uld get support from thinkorswim's in-app chat. it lets you chat and share you screen directly th a live person rht from the app, so you don'teed a comfort pony. oh, what aboumy movational meerkat?

in-app chat on thinkorswim. only at tdmeritrade. on a perfect car, then smash it into a tree. your insurance company raises your rates. maybe you should've done more research on them. for drivers with accident forgiveness, liberty mutual won't raise your rates due to your first accident. and if you do have an accident, our claims centers are available to assist you 24/7. call for a free quote today.

liberty stands with you™. liberty mutual insurance.

with this bull market, i see just that we got to dha our standards just a bit and start valuing stocks in companies on the preponderance of evidence instead of convicting them on a guilty fact or two. for example, the snap ipo prices tonight. while many people are skeptical about the company, and i understand, i think out of the gate it could be a big winner because it does have great reach from much sought after younger demographic. in other words, the advertising firms are saying it's a must buy, so to bet against it from the get-go is probably ill considered. i'm not saying we shouldn't be critical. i'm saying investors may be too negative right now about the faster growing tech companies. let's take the prime example, the case of salesforce.com which

reported last night. i've been interviewing mark benioff, the ceo, almost since the show began, and i've been recommending this $83 stock since it was trading at $8. when other ceos were dodging the show during the great recession, benioff eagerly sought to tell his story because the software platform, which allows so many companies to improve their customer relations and marketing and now of course a lot of other sides of their companies was growing like a weed. remember, not only was salesforce the quickest enterprise software company across the billion dollar sales threshold, as of this year, it will be the fastest to hit the $10 billion threshold. the company has gone from one that seemed like it was bleeding cash that the shorts were all over to one that is stockpiling cash. when benioff came on last night and talked about a remarkable series of growth figures for a mature company, a fiscal year with 26% growth, deferred revenue of 5.5 billion dlz, booked business on and off the balance sheet of an astounding $14.5 billion, you have to

recognize that salesforce has succeeded beyond just about any company's wildest dreams. all of this was in the context of a traditional beat and raise quarter that mark gave you anyway. however, one number, a conservative revenue forecast, one number caused the stock to get hammered in after hours trading, dropping from $83, where it had initially run up to, down to $78 off a couple bucks from the close. i was astounded by this because there's simply no way this company's valuation should be constrained by that one piece of prudent guidance about the next quarter's revs. yet it was at least for the moment. i was astonished. so astonished that i found myself asking mark about how his company could be valued at the same price it was back in december of 2015, now a long time ago, when each quarter since then has produced a colossal amount of new business. i even postulated that this company's stock has gotten so cheap on a relative basis to other growth companies that it made sense, say, for an alphabet, which is cash laden, to spend $80 billion of the cash

it has on hand to just outright buy this $58 billion business, let's say for 36% premium. yeah, 80 bil. why not? alphabet just announced a revolutionary new television product with a subscription revenue stream to eliminate its dependence on advertising. the company has talk the about how it has to boost its enterprise business. see, buying salesforce would give it that enterprise exposure, instantly raise its price to earnings multiple because people think it's trapped by advertising, while accelerating gains as salesforce shareholders might not otherwise get for a bid given how stalled the stock has been for the last 15 months. meanwhile, people wanted to sell the stock because it predicted slower than expected growth for one quarter, even as much of that softness will most likely turn out to be either nothing or currency fluctuations. it made me sick that this stuff is still going on, which is why i was so pleased to see salesforce's stock rocket higher

today like it should have last night. what i'm saying is that in a bull market like this one, you need to look at the preponderance of the evidence before you boot a stock. salesforce is not target, which has lost its way against amazon. it's not valeant, a tattered balance sheet and a big rollover patented to lower margins on generics. salesforce.com is an 18-year-old company with an impeccable record of outperformance over 50 publicly traded quarters. in this market, you don't convict. you give the defendant the benefit of the doubt. the stock of salesforce is a buy, not a sell. and i think that this calculus must have donned on people because by the end of the day, salesforce stock had rallied $2.46, proving that the prosecution should have rested a long, long time ago. stick with cramer. yes, sir, we need your password. the password that i use? yes, sir, your password. there's been another breach! sir! right. okay. i-h-a... ...t-e-m-y-j-o-b-1.

ihatemyjob1? wanna get away? now you can with southwest fares as low as 59 dollars one-way. yes to low fares with nothing to hide. that's transfarency. sfx: clap, clap, ding bp engineers use underwater robots, so they can keep watch over operations below the sea, even from thousands of feet above. because safety is never being satisfied. and always working to be better.

i like to say there's always a bull market somewhere. i promise to try to find it just for you right here on "mad money." i'm jim krarm cramer. see you tomorrow!

. >> welcome to the shark tank, where entrepreneurs seeking an investment will face these sharks. if they hear a great idea, they'll invest their own money or fight each other for a deal. this is "shark tank." ♪ is a couple with a follow-up to a very successful product. hi, sharks. my name is matt griffin. and i'm his wife, pastry chef emily griffin, and we're from carmel, indiana. we own baker's edge, and we are seeking $400,000 for 20% of our company.